AIMOVIG 140 mg/mL
erenumab-aooe · INJECTION, SOLUTION · Amgen Inc
No Recall History
Plain English
AIMOVIG is a injection, solution containing erenumab-aooe at 140 mg/mL, taken subcutaneous. Manufactured by Amgen Inc.
Key Facts
- Brand Name
- AIMOVIG
- Generic Name
- erenumab-aooe
- NDC Code (Product)
55513-843- Manufacturer
- Amgen Inc
- Strength
- 140 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761077
- Marketing Start
- 03/15/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is AIMOVIG used for?
AIMOVIG contains erenumab-aooe. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is AIMOVIG a controlled substance?
AIMOVIG is not classified as a controlled substance by the DEA.
What is the generic name for AIMOVIG?
The generic name for AIMOVIG is erenumab-aooe. There are no other listed brand versions of erenumab-aooe.
What is the NDC code for AIMOVIG 140 mg/mL?
The NDC (National Drug Code) for AIMOVIG 140 mg/mL is 55513-843, listed by Amgen Inc.
Other AIMOVIG Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)